Clinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out

Grant 107995 (H.P.H. Neumann), the Deutsche Forschungsgemeinschaft (NE 571/5-3; H.P.H. Neumann), and the European Union (LSHC-CT-2005-518200; H.P.H. Neumann). C. Eng is the recipient of a Doris Duke Distinguished Clinical Scientist Award, and is the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic. C. Suarez is supported by a grant from the Fondo de Investigaciones Sanitarias (FIS; PI052071) and Red Tematica de Investigacio ́n Cooperativa en Ca ́ncer (RD06/0020/0034). M. Robledo is supported by a grant from FIS (PI042154) and Centro de Investigacio ́n Biome ́dica En Red de Enfermedades Raras.

Repositorio Institucional de la Universidad de Oviedo

Clinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out

Autor(es) y otros:

Fecha de publicación:

Versión del editor:

Citación:

Descripción física:

URI:

ISSN:

DOI:

Patrocinado por:

Colecciones

Ficheros en el ítem

Métricas

Compartir

Estadísticas de uso

Metadatos